Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 760 JPY 0.63% Market Closed
Market Cap: 137.1B JPY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Torii Pharmaceutical Co Ltd stock under the Base Case scenario is 3 856.95 JPY. Compared to the current market price of 4 760 JPY, Torii Pharmaceutical Co Ltd is Overvalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 856.95 JPY
Overvaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.2
P/S
P/S
Price to Sales
2.2
vs History
31
vs Industry
55
Median 3Y
1.9
Median 5Y
1.9
Industry
2.4
Forward
2
More Details
26.5
P/E
P/E
Price to Earnings
26.5
vs History
50
vs Industry
24
Median 3Y
23.3
Median 5Y
23.5
Industry
20.5
Forward
21.9
More Details
36.8
P/OCF
P/OCF
Price to OCF
36.8
vs History
50
vs Industry
0
Median 3Y
36.2
Median 5Y
33.2
Industry
15.4
More Details
42.2
P/FCFE
P/FCFE
Price to FCFE
42.2
vs History
31
vs Industry
0
Median 3Y
41.8
Median 5Y
-7
Industry
22.6
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
9
vs Industry
65
Median 3Y
0.9
Median 5Y
0.8
Industry
2
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
12
vs Industry
69
Median 3Y
1.1
Median 5Y
1
Industry
2.5
Forward
1.4
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
11
vs Industry
66
Median 3Y
2.4
Median 5Y
1.9
Industry
4.9
More Details
12.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.6
vs History
30
vs Industry
36
Median 3Y
9.9
Median 5Y
8.6
Industry
12.6
Forward
11
More Details
13.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.4
vs History
34
vs Industry
38
Median 3Y
10.7
Median 5Y
9.4
Industry
15.6
More Details
24.9
EV/OCF
EV/OCF
Enterprise Value to OCF
24.9
vs History
31
vs Industry
1
Median 3Y
16.7
Median 5Y
14.6
Industry
13.9
More Details
26.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.2
vs History
25
vs Industry
0
Median 3Y
19.5
Median 5Y
0.9
Industry
17.7
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
9
vs Industry
66
Median 3Y
0.7
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Torii Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Torii Pharmaceutical Co Ltd
TSE:4551
133.8B JPY 2.2 26.5 12.6 13.4
US
Eli Lilly and Co
NYSE:LLY
819.5B USD 18.2 77.4 44.9 49.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
393B USD 4.4 27.9 13.1 17.2
DK
Novo Nordisk A/S
CSE:NOVO B
2.3T DKK 8 22.9 15.1 17.1
CH
Roche Holding AG
SIX:ROG
242.5B CHF 4.1 21.1 11.7 13.9
US
Merck & Co Inc
NYSE:MRK
233.7B USD 3.6 13.7 9.2 10.9
UK
AstraZeneca PLC
LSE:AZN
177.6B GBP 4.2 32.6 126.9 193.9
CH
Novartis AG
SIX:NOVN
199.6B CHF 4.4 18.9 11.4 14.7
IE
Endo International PLC
LSE:0Y5F
166.1B USD 71.6 -56.8 265.3 665.3
US
Pfizer Inc
NYSE:PFE
148.1B USD 2.3 18.4 8.7 12.5
P/E Multiple
Earnings Growth PEG
JP
Torii Pharmaceutical Co Ltd
TSE:4551
Average P/E: 28.8
26.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
77.4
48%
1.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
27.9
26%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
22.9
19%
1.2
CH
Roche Holding AG
SIX:ROG
21.1
16%
1.3
US
Merck & Co Inc
NYSE:MRK
13.7
17%
0.8
UK
AstraZeneca PLC
LSE:AZN
32.6
36%
0.9
CH
Novartis AG
SIX:NOVN
18.9
16%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56.8 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.4
29%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Torii Pharmaceutical Co Ltd
TSE:4551
Average EV/EBITDA: 396.8
12.6
16%
0.8
US
Eli Lilly and Co
NYSE:LLY
44.9
30%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.1
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
15.1
15%
1
CH
Roche Holding AG
SIX:ROG
11.7
8%
1.5
US
Merck & Co Inc
NYSE:MRK
9.2
9%
1
UK
AstraZeneca PLC
LSE:AZN
126.9
9%
14.1
CH
Novartis AG
SIX:NOVN
11.4
5%
2.3
IE
E
Endo International PLC
LSE:0Y5F
265.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
8.7
3%
2.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Torii Pharmaceutical Co Ltd
TSE:4551
Average EV/EBIT: 1 701
13.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
49.6
33%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.2
12%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
17.1
16%
1.1
CH
Roche Holding AG
SIX:ROG
13.9
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.9
12%
0.9
UK
AstraZeneca PLC
LSE:AZN
193.9
21%
9.2
CH
Novartis AG
SIX:NOVN
14.7
8%
1.8
IE
E
Endo International PLC
LSE:0Y5F
665.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
12.5
10%
1.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.